Please sign in to follow a disease.
Acute gouty arthritis
Clinical trials for Acute gouty arthritis explained in plain language.
Never miss a new study
Get alerted when new Acute gouty arthritis trials appear
Sign up with your email to follow new studies for Acute gouty arthritis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental pill aims to knock out gout pain within hours
Symptom relief Recruiting nowThis study tests an experimental drug called HRS-2129 in adults experiencing a sudden, painful gout flare. The goal is to see if it can safely reduce joint pain within 24 hours compared to a placebo. Researchers are also looking at how well different doses work and how quickly pa…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase 2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New IV drug aims to tame gout flare pain in hours
Symptom relief Recruiting nowThis Phase 2 trial tests punarlimab, a new IV drug, against a standard steroid injection for quick relief of acute gouty arthritis pain. About 170 adults with frequent gout flares will receive a single dose and report their pain levels over 72 hours. The goal is to see if punarli…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase 2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New gout drug aims to beat pain faster than standard treatment
Symptom relief Recruiting nowThis Phase 2 trial tests an experimental drug called ABP-745 against colchicine (a standard gout medicine) and a placebo in 380 adults with acute gout flares. The goal is to see if ABP-745 reduces pain and swelling better than current options. Participants will take tablets and r…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase 2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC